What one share of Pmv Pharmaceuticals holds
We are a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a well-defined tumor suppressor protein known as the “guardian of the genome,” and normal, or wild-type, p53 has the ability to eliminate cancer cells.
Pmv Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.41 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.34 |
| Cash and investments | $1.49 |
| Book value | $1.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$5.82 | $0.15 | −$5.19 | — | −$15.32 |
| 2019 | — | −$8.35 | $0.04 | −$7.31 | — | −$23.14 |
| 2020 | — | −$2.40 | $0.01 | −$2.29 | — | — |
| 2021 | — | −$1.28 | $0.03 | −$1.06 | — | $6.79 |
| 2022 | — | −$1.61 | $0.18 | −$1.57 | — | $5.38 |
| 2023 | — | −$1.44 | $0.02 | −$1.18 | — | $4.39 |
| 2024 | — | −$1.14 | $0.01 | −$1.01 | — | $3.39 |
| 2025 | — | −$1.48 | $0.00 | −$1.40 | — | $1.96 |
Common questions about Pmv Pharmaceuticals
How much does one share of Pmv Pharmaceuticals earn?
Over the last 12 months, Pmv Pharmaceuticals lost $1.41 for each share.
Does Pmv Pharmaceuticals pay a dividend?
Pmv Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Pmv Pharmaceuticals’s book value per share?
Pmv Pharmaceuticals’s book value is $1.34 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Pmv Pharmaceuticals have?
Each share of Pmv Pharmaceuticals has $1.49 of cash and investments, as of June 30, 2026.
What is Pmv Pharmaceuticals’s free cash flow per share?
−$1.34 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Pmv Pharmaceuticals bought back shares?
Pmv Pharmaceuticals’s share count rose about 1644% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.